Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Demyelinating Disease”

254 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 254 results

Testing effectiveness (Phase 2)WithdrawnNCT02574962
What this trial is testing

Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Mamatha Pasnoor, MD
Testing effectiveness (Phase 2)Looking for participantsNCT06798012
What this trial is testing

TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda 36
Testing effectiveness (Phase 2)UnknownNCT04742400
What this trial is testing

Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 12
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Not applicableStudy completedNCT04562376
What this trial is testing

High-intensity Resistance Training in People With Multiple Sclerosis Experiencing Fatigue

Who this might be right for
Multiple SclerosisFatigueExercise Therapy+2 more
Karolinska Institutet 73
Large-scale testing (Phase 3)Study completedNCT02293460
What this trial is testing

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Laboratoire français de Fractionnement et de Biotechnologies 44
Not applicableStudy completedNCT03969550
What this trial is testing

Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

Who this might be right for
AIDSProgressive Multifocal Leucoencephalopathy (PML)
Fondation Ophtalmologique Adolphe de Rothschild 34
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Large-scale testing (Phase 3)Study completedNCT05084053
What this trial is testing

TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Multifocal Motor Neuropathy (MMN)
Takeda 26
Post-approval studies (Phase 4)Study completedNCT02419378
What this trial is testing

Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital Muenster 15
Not applicableEnded earlyNCT03772717
What this trial is testing

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Emory University 2
Not applicableStudy completedNCT02504840
What this trial is testing

Natural History of Multiple Sclerosis and Its Mimickers

Who this might be right for
Neurologic DisordersHealthy VolunteersMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 104
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Not applicableStudy completedNCT07346924
What this trial is testing

Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) Relapsing Remitting
Cairo University 60
Not applicableUnknownNCT05940922
What this trial is testing

RWE-based Treatment Patterns and Outcomes in CIDP

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barre SyndromeHereditary Amyloidosis
RwHealth 170
Not applicableStudy completedNCT03460951
What this trial is testing

Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)

Who this might be right for
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)CMT (Charcot Marie Tooth Disease)
University Hospital, Clermont-Ferrand 45
Not applicableStudy completedNCT00472992
What this trial is testing

Pregnancy Exposure Registry for Tysabri®

Who this might be right for
Crohn's DiseasePrenatal ExposureMultiple Sclerosis+1 more
Biogen 376
Not applicableLooking for participantsNCT07264426
What this trial is testing

Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study

Who this might be right for
Chronic Inflammatory Demyelinating PolyradiculoneuropathyCIDPCIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
argenx 200
Early research (Phase 1)WithdrawnNCT02939859
What this trial is testing

Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions

Who this might be right for
Multiple SclerosisAutoimmune
Healeon Medical Inc
Not applicableStudy completedNCT03244696
What this trial is testing

Behavior and Activity Monitoring in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Ohio State University 87
Next Page